Table 2.
White n = 20,078 | Black n = 7715 | Asian n = 300 | |||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
Risk of hospitalization | |||||||||
Age < 65 years | 1 | 1 | 1 | ||||||
Age ≥ 65 years | 5.244 | 4.165–6.601 | < 0.001 | 2.7686 | 1.996–3.839 | < 0.001 | 11.746 | 2.176–0.004 | 0.004 |
Female sex | 1 | 1 | 1 | ||||||
Male sex | 1.167 | 0.941–1.447 | 0.159 | 1.551 | 1.136–2.118 | 0.006 | 0.993 | 0.22–0.993 | 0.993 |
T2D No | 1 | 1 | 1 | ||||||
T2D Yes | 2.185 | 1.717–2.782 | < 0.001 | 2.447 | 1.759–3.403 | < 0.001 | 1.313 | 0.212–0.770 | 0.770 |
Metformin | 0.546 | 0.295–1.010 | 0.054 | 0.609 | 0.246–1.506 | 0.283 | 2.1912 | 0.339–0.410 | 0.410 |
SGLT2 inhibitor | 0.713 | 0.348–1.459 | 0.354 | 1 | 1 | ||||
Fatty liver No | 1 | 1 | 1 | ||||||
Fatty liver Yes | 0.710 | 0.315–1.600 | 0.407 | 0.437 | 0.006–3.125 | 0.410 | 1 | ||
BMI < 30 kg/m2 | 1 | 1 | 1 | ||||||
BMI ≥ 30 kg/m2 | 1.538 | 1.210–1.954 | < 0.001 | 1.179 | 0.822–1.691 | 0.371 | 0.35 | 0.042–0.332 | 0.332 |
Risk of critical care | |||||||||
Age < 65 years | 1 | 1 | 1 | ||||||
Age ≥ 65 years | 5.500 | 3.435–8.805 | < 0.001 | 2.695 | 1.518–4.786 | 0.001 | 6.119 | 0.911–41.084 | 0.062 |
Female sex | 1 | 1 | 1 | ||||||
Male sex | 1.502 | 0.972–2.321 | 0.067 | 2.873 | 1.644–5.019 | < 0.001 | 1.71 | 0.274–10.654 | 0.566 |
T2D No | 1 | 1 | 1 | ||||||
T2D Yes | 2.799 | 1.779–4.403 | < 0.001 | 2.485 | 1.407–4.390 | 0.002 | 1.735 | 0.253–11.910 | 0.575 |
BMI < 30 kg/m2 | 1 | 1 | 1 | ||||||
BMI ≥ 30 kg/m2 | 2.008 | 1.192–3.385 | 0.009 | 2.118 | 1.013–4.429 | 0.046 | 0.566 | 0.061–5.251 | 0.616 |
Risk analysis of hospitalization and critical care factors by race, using Cox proportional hazards model, HR = 1 as reference.
BMI body mass index, SGLT2 sodium-glucose cotransporter 2.